Iryna A. Falkenstein, M.D.
Mass. Eye and Ear
243 Charles Street
Boston, MA 02114
|Office Hours:||Wednesdays. Please call for an appointment.|
Mass. Eye and Ear, Longwood
800 Huntington Avenue
Boston, MA 02115
|Office Hours:||Fridays. Please call 617-936-6156 for an appointment.|
|Medical School||Crimea State Medical University, Ukraine|
|Internship||General Surgery, University of Southern California, Los Angeles|
|Residency||Preventive Medicine, University of California, San Diego|
|Residency||Ophthalmology, University of Texas Health Science Center, San Antonio|
|Fellowship||Glaucoma, University of North Carolina, Chapel Hill|
|Fellowship||Pre-residency Research Vitreo-Retinal Fellowship, Shiley Eye Center, University of California, San Diego|
|Teaching Affiliation||Instructor in Ophthalmology, Harvard Medical School|
Native to Ukraine, Dr. Falkenstein received her medical degree at Crimea State Medical University in 1997. After a surgical internship at Los Angeles County Hospital, she continued her ophthalmology training as a resident physician at University of Texas, San Antonio, followed by subspecialty training in glaucoma at the University of North Carolina. She joined Mass. Eye and Ear in 2013.
Dr. Falkenstein’s research focuses on improving imaging techniques for diagnosing glaucoma, such as high resolution optical coherence tomography (OCT). She also is involved in clinical trials elucidating the effects of prostaglandins and statins in the treatment of glaucoma.
She is a professional member of American Academy of Ophthalmology, American Glaucoma Society, Association for Research in Vision and Ophthalmology.
Medical and surgical management of glaucoma and cataracts
Secondary glaucoma, surgical outcomes of glaucoma procedures
For a full publication list, please see her CV.
Intraocular properties of a repository urokinase receptor antagonist a36 peptide in rabbits. Falkenstein IA, Cheng L, Jones TR, Babson B, Kozak I, Freeman WR. Curr Eye Res. 2010;35(8):742-50.
Comparison of visual acuity in macular degeneration patients measured with Snellen and logMAR (ETDRS) study charts. Falkenstein IA, Cochran D, Azen SP, Dustin L, Freeman WR. Ophthalmology. 2008:115(2):319-23.
Changes of intraocular pressure after intravitreal injection of bevacizumab (avastin). Falkenstein IA, Cheng L, Freeman WR. Retina. 2007 Oct;27(8):1044-7.
Imaging vitreomacular interface abnormalities in the coronal plane by simultaneous combined scanning laser and optical coherence tomography. Tammewar AM, Bartsch DU, Kozak I, Falkenstein IA, Freeman WR. Br J Ophthalmol. 2009;93(3):366-72.
Standardized visual acuity resluts associated with primary versus secondary bevacizumab in treatment of neovascular age related macular degeneration. Falkenstein IA, Cheng L, Kozak I, Morrison VL, Freeman WR. Br J Ophthalmol. 2009;93(3):366-72.
To learn more about Dr. Falkenstein, click here to read her“Meet a Specialist” profile.